| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Pelthos Therapeutics Inc.
13D/A
PTHS · 171126204
|
8.3% |
7/3/2025
Event 7/1/2025
|
||||
| Ezra Friedberg | 8.3% | |||||
| Balmoral Financial Group LLC | 3.1% | |||||
| Key Recovery Group LLC | 1.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.